- (a) Specifications. Each single-use vial contains 5, 10, 15, 20, or 30 milligrams (mg) bedinvetmab in an extractable volume of 1 milliliter.
- (b) Sponsor. See No. 054771 in § 510.600(c) of this chapter.
- (c) Conditions of use—(1) Amount. Administer 0.23 mg/pound (0.5 mg/kilogram) body weight monthly by subcutaneous injection.
- (2) Indications for use. For the control of pain associated with osteoarthritis in dogs.
- (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[88 FR 55564, Aug. 16, 2023]